Original Research
Accepted on 06 Jan 2026
Heterogeneity in benefit finding among breast cancer patients: a latent profile analysis and influencing factors
in Breast Cancer
Frontiers in Oncology
- 369 views
- Frontiers in Oncology
- Breast Cancer
- Articles
Type at least 3 characters
1,693 articles
articles
Original Research
Published on 06 Jan 2026
Serial analysis of ESR1 mutations in cell-free DNA from hormone receptor-positive, HER2-negative metastatic breast cancer during palliative endocrine therapy
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2025.1709317
- 810 views
Systematic Review
Published on 06 Jan 2026
Comparative effectiveness of bone-protective interventions for aromatase inhibitors-induced bone loss in postmenopausal women with early breast cancer: a network meta-analysis
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2025.1638370
- 1,078 views
Original Research
Published on 06 Jan 2026
A comparative dosimetric study of hypofractionated radiotherapy with different target volume delineation approaches in breast cancer patients after implant-based reconstruction
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2025.1552813
- 690 views
Original Research
Published on 05 Jan 2026
Comparison of overall survival and disease-free survival for breast-conserving surgery and mastectomy in breast cancer patients receiving neoadjuvant therapy: a matched case-control study from two institutions
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2025.1681937
- 1,148 views
Case Report
Published on 05 Jan 2026
Management of malignant breast phyllodes tumor with rib invasion during pregnancy: a rare case report and literature review
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2025.1703191
- 677 views
Case Report
Published on 02 Jan 2026
Remarkable response to CDK4/6 inhibitor–based endocrine therapy in HR+/HER2− metastatic male breast cancer with visceral crisis: a case report
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2025.1753700
- 804 views
Original Research
Published on 02 Jan 2026
Immediate implant-based breast reconstruction following mastectomy is not associated with delays in adjuvant therapy
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2025.1715130
- 821 views
Original Research
Accepted on 22 Dec 2025
Explainable and Uncertainty-Aware Ensemble Framework with Causal Analysis for Breast Cancer Detection
in Breast Cancer
Frontiers in Oncology
- 117 views
Original Research
Published on 19 Dec 2025
Efficacy comparison of toripalimab versus pembrolizumab in neoadjuvant treatment of breast cancer: impact of chemotherapy regimen and sequence on pathologic complete response
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2025.1699963
- 1,400 views
Case Report
Published on 18 Dec 2025
Trastuzumab deruxtecan in an elderly patient with HR+/HER2-low breast cancer complicated by pleural effusion: a case report and literature review
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2025.1728983
- 1,425 views
Case Report
Published on 17 Dec 2025
Ribociclib plus endocrine therapy in bone marrow visceral crisis: challenging the chemotherapy paradigm in luminal metastatic breast cancer—a case report
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2025.1669057
- 1,042 views
Case Report
Published on 16 Dec 2025
Case Report: Recurrent phyllodes tumor of the breast with progressive malignant transformation
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2025.1652370
- 896 views
Original Research
Published on 16 Dec 2025
Effect of home exercise on prevention and treatment of lymphedema in breast cancer patients
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2025.1665012
- 1,175 views
Correction
Published on 15 Dec 2025
Correction: Predicting breast cancer treatment response and prognosis using AI-based image classification
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2025.1741682
- 493 views
Mini Review
Published on 12 Dec 2025
The gut microbiome as a potential predictive biomarker for breast cancer: emerging association and geographic differences
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2025.1666830
- 1,211 views
Original Research
Published on 12 Dec 2025
A structural equation model study on the influencing factors of sleep disorders in patients with breast cancer undergoing chemotherapy
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2025.1633763
- 912 views
Original Research
Published on 12 Dec 2025
Diagnostic efficacy of multimodal imaging in non-mass-like breast lesions and correlation with pathological findings
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2025.1719528
- 776 views
Study Protocol
Published on 12 Dec 2025
Home-Combo: an online home-based exercise intervention for women with breast cancer undergoing neoadjuvant chemotherapy: study protocol for a 2-arm pragmatic randomized controlled trial
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2025.1682839
- 1,357 views
Systematic Review
Published on 12 Dec 2025
Comparative efficacy of various physical therapies on pain, fatigue, quality of life and functional impairment in breast cancer survivors: a network meta-analysis of randomized controlled trials
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2025.1699682
- 1,264 views
Case Report
Published on 11 Dec 2025
Malignant phyllodes tumor of the breast with short-term multiple recurrences and systemic distant metastasis: a case report and literature review
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2025.1715674
- 984 views
Original Research
Published on 11 Dec 2025
EMP1 regulates cell proliferation, migration and invasion in triple negative breast cancer through PI3K‐AKT signaling
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2025.1701470
- 1,019 views
Original Research
Published on 11 Dec 2025
Leucine-rich repeat neuronal 1 as a prognostic indicator and functional modulator in breast cancer
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2025.1724785
- 1,174 views
Original Research
Published on 11 Dec 2025
Toxicity profiles of cyclin-dependent kinase 4/6 inhibitors: safety analysis from clinical trials and the FDA adverse event reporting system
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2025.1673284
- 1,481 views